Intrinsic Value of S&P & Nasdaq Contact Us

Pfizer Inc. PFE NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
65/100
3/7 Pass
SharesGrow Intrinsic Value
$17.48
-35.6%
Analyst Price Target
$27.50
+1.4%

Pfizer Inc. (PFE) reported total assets of $208.16B and total liabilities of $121.39B for quarter ending 2025-12-31, resulting in total equity of $86.78B.

The company held $13.6B in cash and short-term investments. Total debt stood at $67.42B, with net debt of $66.27B. The Debt-to-Equity (D/E) ratio was 0.78 (moderate).

Current ratio is 1.16, suggesting adequate short-term liquidity. Interest coverage is 5.2x (adequate).

Criteria supported by this page:

  • HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (94/100) — Total assets $208.16B and equity $86.78B support the company's competitive scale
  • VALUE (61/100) — Debt-to-Equity 0.78 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 65/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
65/100
SG Score
View full scorecard →
VALUE
61/100
Price-to-Earnings & upside
→ Valuation
FUTURE
34/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
94/100
Proven by this page
~
GROWTH
58/100
→ Income
~
INCOME
55/100
→ Income
Pfizer Inc. Balance Sheet History
Metric Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Total Assets $208.16B$208.73B$206.1B$208.03B
Total Liabilities $121.39B$115.64B$117.08B$117.39B
Total Debt $67.42B$61.71B$61.8B$61.29B
Cash & Investments $13.6B$14.98B$13.25B$17.32B
Total Stockholders Equity $86.48B$92.8B$88.7B$90.34B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message